Neurobiological Technologies, Inc.
NTII · OTC
6/30/2010 | 6/30/2009 | 6/30/2008 | 6/30/2007 | |
|---|---|---|---|---|
| Market Cap | $1,858 | $18,175 | $27,601 | $54,048 |
| - Cash | $1,842 | $8,230 | $27,941 | $5,538 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $16 | $9,945 | -$340 | $48,510 |
| Revenue | – | $26,350 | $14,760 | $17,673 |
| % Growth | – | 78.5% | -16.5% | – |
| Gross Profit | – | $26,218 | $14,555 | $17,443 |
| % Margin | – | 99.5% | 98.6% | 98.7% |
| EBITDA | – | $3,255 | -$16,492 | -$15,371 |
| % Margin | – | 12.4% | -111.7% | -87% |
| Net Income | – | $3,123 | -$16,322 | -$14,128 |
| % Margin | – | 11.9% | -110.6% | -79.9% |
| EPS Diluted | – | 0.12 | -0.84 | -3.26 |
| % Growth | – | 114.3% | 74.2% | – |
| Operating Cash Flow | – | -$16,429 | -$20,697 | -$13,154 |
| Capital Expenditures | – | -$2 | -$11 | -$66 |
| Free Cash Flow | – | -$16,431 | -$20,708 | -$13,220 |